PN 74008
RN 00008 
AN 75009735
AU Hoiby-N.
TI Epidemiological investigations of the respiratory tract bacteriology
   in patients with cystic fibrosis.
SO Acta-Pathol-Microbiol-Scand [B]. 1974 Aug. 82(4). P 541-50.
MJ CYSTIC-FIBROSIS: mi.  BACTERIA: ip.  BACTERIA: ip.
   RESPIRATORY-TRACT-INFECTIONS: mi.
MN ADOLESCENCE.  CHILD.  CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: th, dt.
   STREPTOCOCCUS-PNEUMONIAE: ip.  ESCHERICHIA-COLI: ip.
   FOLLOW-UP-STUDIES.  HAEMOPHILUS-INFLUENZAE: ip.  HUMAN.  INFANT.
   RESPIRATORY-THERAPY.  KLEBSIELLA: ip.  PROTEUS: ip.
   PSEUDOMONAS-AERUGINOSA: ip.  SPUTUM: mi.  STAPHYLOCOCCUS: ip.
   STREPTOCOCCUS: ip.  SULFONAMIDES: tu.  TIME-FACTORS.  TRACHEA: mi.
AB Seventy patients with cystic fibrosis treated as out-patients in a
   cystic fibrosis clinic have been followed during one year by
   monthly bacteriological examinations of tracheal secretions.  The
   daily impression obtained in the laboratory is expressed by the
   mean point prevalence rate of Pseudomonas aeruginosa: 44 per cent,
   Staphylococcus aureus: 39 per cent, Haemophilus influenzae: 17 per
   cent, Diplococcus pneumoniae: 8 per cent, and miscellaneous other
   bacteria, mainly Enterobacteriaceae: 8 per cent.  The fluctuations
   of the bacteriology are described by additional epidemiological
   terms: At one or more examinations during the study (period
   prevalence rate), 90 per cent of the patients harboured St. aureus,
   64 per cent Ps. aeruginosa (mainly mucoid strains), 64 per cent H.
   influenzae, 37 per cent D. pneumoniae, and 30 per cent miscellaneous
   other bacteria, mainly Enterobacteriaceae.  This pattern was found
   in all age groups with minor age-dependent modifications, especially
   as regards Enterobacteriaceae.  Ps. aeruginosa was predominating as
   regards chronic colonization which reflects the most difficult
   therapeutic problems, the period prevalence rate being 39 per cent
   in contrast to St. aureus: 10 per cent, and H. influenzae: 1 per
   cent.  St. aureus was predominating as regards new colonization and
   recolonization which reflect the problems of prevention, the
   incidence rate of new colonization and recolonization per risk group
   being 84 per cent, followed by H. influenzae: 62 per cent, Ps.
   aeruginosa: 43 per cent, and D. pneumoniae: 30 per cent.  The
   results show that the bacteriological problems in cystic fibrosis
   are still considerable as regards therapy as well as prevention.
   Although many species may colonize the respiratory tracts of these
   patients, the main clinical problems concern Ps. aeruginosa and St.
   aureus; the reason why is discussed.
RF 001   BURNS MW              LANCET                           1   270 968
   002   COWAN ST              MANUAL FOR THE IDENTIFICATION            965
   003   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962
   004   DOGGETT RG            IN: LAWSON D PROC 5TH INT CF         175 969
   005   DOSSETT JH            J IMMUNOL                      103  1405 969
   006   FEIGELSON J           MOD PROBL PEDIATR               10   214 967
   007   GIFFORD RM            J S CAROLINA MED ASSOC          68   204 972
   008   GUSTAFSON GT          J IMMUNOL                       98  1178 967
   009   HALBERT SP            PEDIATRICS                      26   792 960
   010   HALBERT SP            MOD PROBL PEDIATR               10   144 967
   012   HUANG NN              J PEDIATR                       59   512 961
   013   HUMPHREY JH           ADV IMMUNOL                     11    75 969
   014   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973
   016   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974
   018   IACOCCA VF            AM J DIS CHILD                 106   315 963
   019   IACOCCA VF            ARCH DIS CHILD                  43   220 968
   020   JENSEN K              THESIS                                   959
   022   KILBOURN JP           LANCET                           2   878 970
   023   LAWSON D              IN: WATT PJ                           69 970
   024   MACMAHON B            EPIDEMIOLOGY PRINCIPLES AND M            970
   025   MADDOCKS JL           LANCET                           1   793 969
   026   MARTIN RR             J IMMUNOL                      102   437 969
   027   MARTINEZ-TELLO FJ     J IMMUNOL                      101   989 968
   028   MAY JR                CHEMOTHERAPY OF CHRONIC BRONC            968
   029   MAY JR                ARCH DIS CHILD                  47   908 972
   030   MEARNS MB             ARCH DIS CHILD                  47   902 972
   031   SCHWARTZ RH           AM J DIS CHILD                 111   408 966
   032   SJOQUIST J            IN: KILLANDER J                      341 967
   033   STALENHEIM G          IMMUNOCHEMISTRY                 10   501 973
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   559 974
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974
     3   HOIBY N               SCAND J RESPIR DIS              56    38 975
     4   BERGAN T              ACTA PATH MICROBIOL SCAND (B)   83   553 975
     5   HOFF GE               ACTA PATH MICROBIOL SCAND (B)   83   219 975
     6   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   83   328 975
     7   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   83   459 975
     8   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   83   549 975
     9   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   83   469 975
    10   WEEKE B               DAN MED BULL                    23   155 976
    11   BATTEN J              POSTGRAD MED J                  52   571 976
    12   HOIBY N               SCAND J RESPIR DIS              57    37 976
    13   HOIBY N               SCAND J RESPIR DIS              57   103 976
    14   VERON M               BULL INSTITUT PASTEUR           74   295 976
    15   WOOD RE               AM REV RESPIR DIS              113   833 976
    16   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
    17   CLARKE CW             CLIN ALLERGY                     7   527 977
    18   PIVETTA OH            PEDIATR RES                     11  1133 977
    19   HOIBY N               SCAND J RESPIR DIS              58    65 977
    20   LAU WK                PEDIATRICS                      60   372 977
    21   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   107 977
    22   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   142 977
    23   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   85    57 977
    24   PARRY MF              J PEDIATR                       90   144 977
    25   OLLING S              SCAND J INFECT DIS            1977     7 977
    26   SCHIOTZ PO            HUM HERED                       28   293 978
    27   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   86    37 978
    28   HAMPTON KD            J CLIN MICROBIOL                 9   632 979
    29   HOIBY N               MONOGR PAEDIATR                 10   138 979
    30   PAPORISZ U            MONOGR PAEDIATR                 10    31 979
    31   FRIIS B               SCAND J INFECT DIS              11   211 979
    32   MAYBURY BA            ANTIMICROB AGENTS CHEMOTHER     15   494 979
    33   KRAUSE PJ             CURR THER RES CLIN EXP          25   609 979
    34   HOIBY N               ACTA PAEDIATR SCAND             68   495 979
    35   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87     1 979
    36   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (B)   87   345 979
    37   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (B)   87   337 979
    38   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87   229 979
    39   PAPORISZ U            EUR J PEDIATR                  130   259 979
    40   KILBOURN JP           PEDIATR RES                     14   259 980
    41   WOODS DE              INFECT IMMUN                    30   694 980
    42   SKOV PS               ALLERGY                         35    23 980
    43   MARTIN AJ             ARCH DIS CHILD                  55   604 980
    44   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   88   125 980
    45   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   88   275 980
    46   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981
    47   PETERSEN NT           ACTA PAEDIATR SCAND             70   623 981
    48   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   89   185 981
    49   BOYCE JR              INFECT IMMUN                    37   695 982
    50   KOCH C                ALLERGY                         37   191 982
    51   PERMIN H              ALLERGY                         37    93 982
    52   MOLLER NE             EUR J RESPIR DIS                63   130 982
    53   SZAFF M               ACTA PAEDIATR SCAND             71   821 982
    54   KRAEMER R             EUR J PEDIATR                  138   172 982
    55   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982
    56   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
    57   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982
    58   KOLLBERG H            ACTA PAEDIATR SCAND SUPPL 301 1982    15 982
    59   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982
    60   ZIMAKOFF J            J HOSP INFECT                    4    31 983
    61   KERCSMAR CM           J ANTIMICROB CHEMOTHER          12   289 983
    62   KLINGER JD            INFECT IMMUN                    39  1377 983
    63   SCHIOTZ PO            ACTA PAEDIATR SCAND             72   283 983
    64   DORING G              J INFECT DIS                   147   744 983
    65   PRESSLER T            ACTA PAEDIATR SCAND             73   541 984
    66   LIEBERMAN MM          SURV SYNTH PATHOL RES            4   312 985
    67   SCULLY BE             REV INFECT DIS                   7  S669 985
    68   STANISLAVSKY ES       ACTA MICROBIOL HUNG             32    49 985
    69   JACQUOT J             INFECT IMMUN                    47   555 985
    70   BLUMER JL             AM J MED                        79    37 985
    71   SCHONHEYDER H         ACTA PATH MICROB IMMU SCA (B)   93   105 985
    72   TABLAN OC             J PEDIATR                      107   382 985
    73   HILL DJS              MED J AUST                     143   230 985
    74   KRIEG DP              J CLIN MICROBIOL                24   986 986
    75   RILEY TV              FEMS MICROBIOL LETTERS          33    55 986
    76   PEDERSEN SS           ACTA PAEDIATR SCAND             75   840 986